EP2399909
Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.7.2007EP published:
26.8.2015EP application number:
11166123.7
EPO information:
European Patent Register
Max expiry date:
4.7.2027
Title:
Hydroxylated cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
Timeline
Today
5.7.2007EP application
26.8.2015EP Publication
Owner
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, 80301, Boulder, CO, US
Name:
Genentech, Inc.Address:
1 DNA Way, 94080-4490, South San Francisco CA, US
Inventor
Name:
Mitchell, Ian, S.Address:
Lafayette, CO, US
Name:
Blake, James, F.Address:
Longmont, CO, US
Name:
Xu, RuiAddress:
Longmont, CO, US
Name:
Kallan, Nicholas, C.Address:
Boulder, CO, US
Name:
Xiao, DengmingAddress:
Longmont, CO, US
Name:
Spencer, Keith, LeeAddress:
Lyons, CO, US
Name:
Bencsik, Josef, R.Address:
Longmont, CO, US
Name:
Liang, JunAddress:
Palo Alto, CA, US
Name:
Safina, BrianAddress:
Redwood City, CA, US
Name:
Zhang, BirongAddress:
Union City, CA, US
Name:
Chabot, ChristineAddress:
San Mateo, CA, US
Name:
Do, StevenAddress:
San Jose, CA, US
Name:
Wallace, Eli, W.Address:
Lyons, CO, US
Name:
Banka, Anna, L.Address:
Longmont, CO, US
Name:
Schlachter, Stephen, T.Address:
Boulder, CO, US
Priority
Number:
818718 PDate:
6.7.2006Country:
US
Classification
Categories:
C07D 239/70, C07D 401/12, C07D 403/04, C07D 403/12, C07D 407/12, C07D 409/12, C07D 409/14, A61K 31/517, A61P 35/00